Clinical Trial

Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee

Name: Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee — clinical trial record (NCT07550231)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine the optimal dose of AD-211 in patients with osteoarthritis of the knee.

Trial Details

NCT Number	NCT07550231
Lead Sponsor	Addpharma Inc.
Conditions	Osteoarthritis of the Knees
Enrollment	200 participants
Start Date	2026-06
Primary Completion	2027-03 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-04-24